NFKB1 and cancer: In this respect, it should be emphasized that NFκB is constitutively activated in a number of hematologic and solid tumors and is one of the major transcription factors associated with cancer progression, inhibition of apoptosis, limitless replicative potential, tissue invasion and metastasis [58].